Triple 000 and Sub-penny Chart Plays

[DewmBoom]

$BIEL: Week in Review

320 million shares traded this week with a 5 day moving average of 0.0030 for a total of $960,000.

The stock showed a huge bullish resilience this week after the fraction of a fraction of 1% introduced a scare for the increase in AS by 5 billion shares to 25 billion shares. This presented a huge opportunity for longs to grab more shares at the cheap. I managed to grab 3 million shares at 0.0024 and went straight to the mattress.

The stock is showing a huge improvement in technicals where the 100 day moving average is now at 0.0020, which is very impressive upward movement, with a trading volume of 8 billion shares.

The fundamentals are converging for the second half of the year with some huge milestones to take place from full body actipatch approval to RecoveryRx to Dr Scholl’s deal to a US retailer entry.

Add the technical to the fundamental and you get a company that is going to shoot up passing 0.01 at the speed of light.

Remember that Biel is my no 1 stock pick for 2018 with a target price well north of 0.01.

In summary, invest in Biel and don’t trade. Slap the ask early Monday and sleep like a baby for the rest of the year. Actipatch is the only wearable affordable FDA approved PEMF device with patent protection till 2029.